Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patientsWilma Barcellini, Alberto Zanella, Gianluca Gaïdano et al.|Blood|2014Cited by 371
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studiesWilma Barcellini, Alberto Zanella, Francesco Zaja et al.|Blood|2012Cited by 144
New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to TherapyWilma Barcellini, Bruno Fattizzo, Anna Zaninoni et al.|Journal of Clinical Medicine|2020Cited by 118
Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centersWilma Barcellini, Agostino Cortelezzi, Anna Zaninoni et al.|American Journal of Hematology|2018Cited by 80
Evans syndrome in adults: an observational multicenter studyBruno Fattizzo, Wilma Barcellini, Marc Michel et al.|Blood Advances|2021Cited by 70